Reading this on a mobile device? Try our optimized mobile version here:

February 15, 2013America's Health Insurance Plans

  Top Stories 
  • Experts tie chemotherapy to slight increase in AML risk
    Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers faced an increased risk of developing acute myeloid leukemia, according to a new study. However, treatment was associated with lower AML risk in patients who had ovarian cancer, myeloma, and possibly lung cancer, researchers said. The findings appear in the journal Blood. HealthDay News (2/14) LinkedInFacebookTwitterEmail this Story
Margins are getting tighter. It’s a reality of healthcare that we all need to face. But there is an answer, and it’s in the software you use to administer your business. Whether it’s an in-house deployment, a hosted solution or complete BPO services that you require; we have what you need to improve your bottom line. Click here to learn more.
  Providers & Suppliers 
  • Free clinics may help reduce unnecessary ED visits, costs
    Patients who sought care at free health clinics before visiting the emergency department were less likely to use the ED as their initial source of health care, according to new research, suggesting that clinics may help reduce unnecessary ED utilization. Researchers noted clinic utilization is more cost-effective than ED use. The study was published in the Journal of Health Care for the Poor and Underserved. (2/13) LinkedInFacebookTwitterEmail this Story
  • Survey finds varied practice patterns for type 2 diabetes
    A survey of family physicians and other practitioners who treat patients with type 2 diabetes shows varied practice patterns and knowledge gaps, researchers reported in the journal Clinical Diabetes. The study found while most practitioners followed evidence-based guidelines, they had different levels of understanding or opinions in areas such as guidelines, insulin and incretin therapies, and appropriate reasons for referral. News (2/13) LinkedInFacebookTwitterEmail this Story
Are you ready for machine learning?
With the advent of big data, the amount of data and our ability to process it has increased exponentially. It's an environment perfectly suited for machine learning. So how can you make it part of your analytic infrastructure? This e-book highlights the capabilities of machine learning, and best practices you can implement to take full advantage of it. Download Here.
  Medical Update 
  • Study looks at human metapneumovirus in hospitalized children
    Hospital records from three U.S. counties from 2003 to 2009 showed that 6% of 3,490 hospitalized children had human metapneumovirus and 7% of 3,001 pediatric emergency department visits were linked to the virus. Children infected with the virus were more likely to have pneumonia or asthma, require oxygen treatment and have longer stays in intensive care units, researchers said. The findings appear in the New England Journal of Medicine. HealthDay News (2/13) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • FDA grants Second Sight approval for "bionic eye"
    Second Sight Medical Products obtained federal approval for its Argus II Retinal Prosthesis System, designed to help patients with retinitis pigmentosa regain some vision. The "bionic eye" uses a small camera that transmits images to sensors implanted in the patient's eye. HealthDay News (2/14) LinkedInFacebookTwitterEmail this Story
  Health Insurance Plan Company News 
  Vendor Company News 
  Pharma News 
  • FDA updates watch list by adding 3 drugs
    The FDA added GlaxoSmithKline's leukemia drug Arzerra, or ofatumumab; UCB's epilepsy, liver and kidney drug Vimpat, or lacosamide; and Acorda Therapeutics' multiple sclerosis, kidney and liver drug Ampyra, or dalfampridine, to its list of products to monitor due to new safety information or possible signs of serious risks. The FDA received reports of potential adverse events involving the treatments in last year's third quarter. A sunscreen was also added to the list. Medscape (free registration) (2/12) LinkedInFacebookTwitterEmail this Story
Three Conferences, One Week
Join AHIP for the Dual Eligibles Summit, March 12; National Policy Forum, March 13-14; or Exchange Conference, March 14-15 in Washington, D.C., for an informative exchange on the challenges and opportunities in 2013 and beyond. Click here for details and click here to register.
  Policy Watch 
  • Reps urge USPS to protect home delivery of prescription drugs
    The U.S. Postal Service must ensure that people who receive prescription drugs through the mail are not harmed by proposed cutbacks, 88 House members wrote in a letter to the postmaster general. The proposed cutbacks would end Saturday delivery of letters, but the lawmakers noted delivery of medications sent in small envelopes or via First Class mail would be affected. The Hill/Healthwatch blog (2/13), Drug Store News (2/13) LinkedInFacebookTwitterEmail this Story
  AHIP News 
  • Improve your ACA knowledge with new online courses
    For a better understanding of the Affordable Care Act (ACA), register for AHIP’s new Affordable Care Act (ACA) Compliance Online Series. Available course topics include Medicare, Exchanges, the Summary of Benefits and Coverage, and Accountable Care Organizations, with more programs planned in the near future. Learn more. LinkedInFacebookTwitterEmail this Story
  • Save $500 on connecting with health plans
    Becoming an AHIP Affiliate Organization Member is a great way to learn about the solutions health plans are seeking, and to showcase your products and services. Through Friday, March 15, you can save $500 on your membership when you mention the discount code AffiliateOrg13. For details, contact a member of AHIP’s Business Development Team at or 866-707-AHIP (2447) today. LinkedInFacebookTwitterEmail this Story
  • Health systems change initiative launched
    AHIP Foundation announces the launch of the Institute for Health Systems Solutions (IHSS), an initiative designed to help advance new ideas regarding the delivery and financing of health care through credible, independent research and analysis. Learn more. LinkedInFacebookTwitterEmail this Story
Learn more about AHIP ->About AHIP  |  Join AHIP  |  Educational Opportunities
AHIP Select  |  AHIP Coverage Blog

Position TitleCompany NameLocation
Vice President Member GroupLouisiana Health Cooperative, Inc.New Orleans, LA
Integrated Market Medical ExecutiveKindred HealthcareLas Vegas, NV
Vice President, Provider Relations & CredentialingConfidentialWyomissing, PA
Vice President, Health Plan OperationsSatellite Health Plan, Inc.San Jose, CA
Manager, Payor RelationsThe joint CommissionOakbrook Terrace, IL
Government Relations and Compliance OfficerLouisiana Health Cooperative, Inc.Metarie, LA
Vice President and Chief Financial OfficerLouisiana Health Cooperative Inc. (LAHC)Metarie, LA
Director of Product Management, UPDCouncil for Affordable Quality Healthcare (CAQH)Washington, DC
CAQH CORE Manager, Education, Outreach and Participant RelationsCouncil for Affordable Quality HealthcareWashington, DC
CAQH Managing Director, Finance and AdministrationCouncil for Affordable Quality HealthcareWashington, DC
Asst Director, Medicare Prod. Analytics/Rev. Mgmt CambiaPortland, OR
Click here to view more job listings.

If you want to live a happy life, tie it to a goal. Not to people or things."
--Albert Einstein,
German-born theoretical physicist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Sales Account Director:  Matt Kavney (202) 607-5368
Job Board: Jasmine Rogers (202) 640-4684
AHIP Solutions Team
Managing Editor, Online Publishing:
Yvonne Chanatry

 Recent AHIP Solutions SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual AHIP endorsements. The news reported in SmartBrief does not necessarily reflect the official position of AHIP.